Although all eligible patients had a diagnosis of XLH, some included patients had intact FGF23 levels >30 pg/mL, but did not have confirmed PHEX mutations in either themselves or a first-degree relative. The gene discussed is FGF23; the disease is X-linked hypophosphatemia.